FDA Commissioner Marty Makary announced last week that the federal agency will begin offering performance-based cash bonuses to staff who complete drug reviews ahead of schedule. The pilot program, dubbed the “Reviewer Recognition and Excellence” program, involved “some wrangling” by the commissioner, who apparently told FDA staffers as much, according to the Associated Press.
Экс-посол Британии жестко высказался об агрессии США против Ирана08:51。业内人士推荐91视频作为进阶阅读
Compose AI is a company that specializes in developing。快连下载安装是该领域的重要参考
0000010 5a 92 ad c2 04 8f 90 30 0d 06 09 2a 86 48 86 f7。体育直播是该领域的重要参考
Последние новости